In this episode, we talk to Jeff Holder and Adam Siebert, Partners and Managing Directors at L.E.K. Consulting, about the rapidly evolving world of advanced drug modalities. 

With years of experience advising clients across the life sciences industry, Jeff and Adam sit at the intersection of cutting-edge science and the real-world constraints of getting medicines to patients. Together, we unpack the past, present and future of advanced drug modalities, the science and the strategic implications behind them, and explore what it really takes to bring these breakthroughs to market.

If you want to connect with us - we would love to hear from you:
Linkedin: https://www.linkedin.com/company/cures-capital-podcast

If you prefer to watch the episode in video format, you can also get the podcast on YouTube, just search for Cures & Capital.

If you want to connect with Jeff Holder:
Linkedin: https://www.linkedin.com/in/jeff-holder-ph-d-7a391087/

If you want to connect with Adam Siebert:
Linkedin: https://www.linkedin.com/in/adam-siebert-8772b327/

If you want to read more about/from L.E.K. Consulting:
Website: https://www.lek.com/

Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.